Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMPACT - Intensive Care Outcome Prediction Using Admission Carbohydrate-deficient Transferrin A Prospective Single-center Cohort Study

NCT07632716 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT07632716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07632716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMPACT - Intensive Care Outcome Prediction Using Admission Carbohydrate-deficient Transferrin A Prospective Single-center Cohort Study
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Recruiting
Start date
July 2, 2026
Completion date
July 31, 2028
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol misuse, critical illness, intensive care (icu)